News ContraFect Corporation

Stocks

CFRXQ

US2123264093

Biotechnology & Medical Research

Market Closed - OTC Markets 10:53:43 2026-09-08 EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	-

24-02-09	Bidding Procedure Approved for ContraFect Corporation	CI
24-01-11	Motion for Asset Sale Filed by ContraFect Corporation	CI

All News

Mentions Relevance

24-02-09	Bidding Procedure Approved for ContraFect Corporation	CI
24-01-11	Motion for Asset Sale Filed by ContraFect Corporation	CI
23-12-05	ContraFect Corporation Announces Resignation of Michael Messinger as Chief Financial Officer	CI
23-12-05	ContraFect Corporation Announces Management Resignations	CI
23-12-05	ContraFect Corporation Announces Resignation of Michael Messinger as Chief Executive Officer	CI
23-12-04	ContraFect Corporation Filed for Bankruptcy	CI
23-11-15	ContraFect Corporation Announces Chief Executive Officer Changes	CI
23-11-15	ContraFect Corporation Announces Executive Changes	CI
23-11-15	ContraFect Corporation Appoints Michael Messinger as Chief Financial Officer	CI
23-11-15	ContraFect Corporation Implements Restructuring Plan Resulting in Reduction to Workforce from A Total of 23 Employees to Five Employee	CI
23-11-14	ContraFect: Q3 Earnings Snapshot	AQ
23-11-14	ContraFect Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-11-13	ContraFect Corporation(OTCPK:CFRX) dropped from S&P TMI Index	CI
23-11-08	ContraFect Corporation(OTCPK:CFRX) dropped from NASDAQ Composite Index	CI
23-10-16	ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study	AQ
23-09-19	ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development	AQ
23-09-18	ContraFect Submits Investigational New Drug Application for Bacterial Pneumonia Treatment	MT
23-09-18	ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370	AQ
23-08-28	ContraFect to Present at the World Anti-Microbial Resistance Congress 2023	AQ
23-08-15	ContraFect : Q2 2023 Investor Presentation	PU
23-08-14	ContraFect: Q2 Earnings Snapshot	AQ
23-08-14	ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update	AQ
23-08-14	ContraFect Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-06-27	ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million	AQ
23-06-23	ContraFect Corporation(NasdaqCM:CFRX) dropped from Russell Microcap Value Index	CI